Elective and emergent endovascular treatment of subclavian @entity438 and XXXX .

@entity1 @entity438 @entity1410 @entity551 @entity385 @entity130 @entity1756
PURPOSE: To demonstrate our short and long-term results after transbrachial treatment of subclavian @entity438 and @entity130 with stent-grafts in elective and emergency settings. METHODS: Ten of 12 consecutive @entity1 (6 @entity1 ; mean age 63.8 years, range 38-80) were treated electively with commercially prepared endografts delivered via a transbrachial access to repair a subclavian @entity438 (n=3) or an injury from a misplaced central venous catheter (n=7). Two @entity1 required emergency treatment for a @entity1756 in one and an unintentional arterial puncture during placement of a central venous access in the other. Stent-graft patency during follow-up was assessed by physical examination with @entity551 in all @entity1 ; computed tomography angiography (CTA) was performed in available @entity1 . RESULTS: Successful deployment of stent-grafts with sealing of the lesion was achieved in all cases. There were 2 (17%) procedural complications. One @entity1 developed an access-site @entity1410 that required surgical revision. The second @entity1 , who had a right @entity130 , suffered an @entity385 . The primary stent-graft patency during follow-up (mean 11.6 months) was 100%. CTA examinations in 7 @entity1 at a mean 18 months showed strut dislocation at the thoracic outlet without luminal narrowing in 1 @entity1 . A 50% intraluminal narrowing due to compression between the clavicle and the first rib occurred in another @entity1 . Six @entity1 with a mean follow-up of 23 months (range 0.3-4.5 years) are still alive with patent stent-grafts. CONCLUSIONS: Endovascular stent-graft treatment of subclavian @entity438 and @entity130 is a less invasive alternative to surgical repair. Long-term results must still be confirmed in further studies.
